242 related articles for article (PubMed ID: 18680714)
1. T cells potentiate PTH-induced cortical bone loss through CD40L signaling.
Gao Y; Wu X; Terauchi M; Li JY; Grassi F; Galley S; Yang X; Weitzmann MN; Pacifici R
Cell Metab; 2008 Aug; 8(2):132-45. PubMed ID: 18680714
[TBL] [Abstract][Full Text] [Related]
2. Disruption of PTH receptor 1 in T cells protects against PTH-induced bone loss.
Tawfeek H; Bedi B; Li JY; Adams J; Kobayashi T; Weitzmann MN; Kronenberg HM; Pacifici R
PLoS One; 2010 Aug; 5(8):e12290. PubMed ID: 20808842
[TBL] [Abstract][Full Text] [Related]
3. T cell-expressed CD40L potentiates the bone anabolic activity of intermittent PTH treatment.
Robinson JW; Li JY; Walker LD; Tyagi AM; Reott MA; Yu M; Adams J; Weitzmann MN; Pacifici R
J Bone Miner Res; 2015 Apr; 30(4):695-705. PubMed ID: 25359628
[TBL] [Abstract][Full Text] [Related]
4. T cells, osteoblasts, and osteocytes: interacting lineages key for the bone anabolic and catabolic activities of parathyroid hormone.
Pacifici R
Ann N Y Acad Sci; 2016 Jan; 1364(1):11-24. PubMed ID: 26662934
[TBL] [Abstract][Full Text] [Related]
5. Parathyroid Diseases and T Cells.
Neale Weitzmann M; Pacifici R
Curr Osteoporos Rep; 2017 Jun; 15(3):135-141. PubMed ID: 28421466
[TBL] [Abstract][Full Text] [Related]
6. Accentuated osteoclastic response to parathyroid hormone undermines bone mass acquisition in osteonectin-null mice.
Machado do Reis L; Kessler CB; Adams DJ; Lorenzo J; Jorgetti V; Delany AM
Bone; 2008 Aug; 43(2):264-273. PubMed ID: 18499553
[TBL] [Abstract][Full Text] [Related]
7. B cells and T cells are critical for the preservation of bone homeostasis and attainment of peak bone mass in vivo.
Li Y; Toraldo G; Li A; Yang X; Zhang H; Qian WP; Weitzmann MN
Blood; 2007 May; 109(9):3839-48. PubMed ID: 17202317
[TBL] [Abstract][Full Text] [Related]
8. Cyclic adenosine monophosphate/protein kinase A mediates parathyroid hormone/parathyroid hormone-related protein receptor regulation of osteoclastogenesis and expression of RANKL and osteoprotegerin mRNAs by marrow stromal cells.
Kondo H; Guo J; Bringhurst FR
J Bone Miner Res; 2002 Sep; 17(9):1667-79. PubMed ID: 12211438
[TBL] [Abstract][Full Text] [Related]
9. Ovariectomy disregulates osteoblast and osteoclast formation through the T-cell receptor CD40 ligand.
Li JY; Tawfeek H; Bedi B; Yang X; Adams J; Gao KY; Zayzafoon M; Weitzmann MN; Pacifici R
Proc Natl Acad Sci U S A; 2011 Jan; 108(2):768-73. PubMed ID: 21187391
[TBL] [Abstract][Full Text] [Related]
10. Gender differences in the response of CD-1 mouse bone to parathyroid hormone: potential role of IGF-I.
Wang Y; Sakata T; Elalieh HZ; Munson SJ; Burghardt A; Majumdar S; Halloran BP; Bikle DD
J Endocrinol; 2006 May; 189(2):279-87. PubMed ID: 16648295
[TBL] [Abstract][Full Text] [Related]
11. IL-6 is not required for parathyroid hormone stimulation of RANKL expression, osteoclast formation, and bone loss in mice.
O'Brien CA; Jilka RL; Fu Q; Stewart S; Weinstein RS; Manolagas SC
Am J Physiol Endocrinol Metab; 2005 Nov; 289(5):E784-93. PubMed ID: 15956054
[TBL] [Abstract][Full Text] [Related]
12. Parathyroid hormone stimulates TRANCE and inhibits osteoprotegerin messenger ribonucleic acid expression in murine bone marrow cultures: correlation with osteoclast-like cell formation.
Lee SK; Lorenzo JA
Endocrinology; 1999 Aug; 140(8):3552-61. PubMed ID: 10433211
[TBL] [Abstract][Full Text] [Related]
13. The Proteasome Inhibitor Carfilzomib Suppresses Parathyroid Hormone-induced Osteoclastogenesis through a RANKL-mediated Signaling Pathway.
Yang Y; Blair HC; Shapiro IM; Wang B
J Biol Chem; 2015 Jul; 290(27):16918-28. PubMed ID: 25979341
[TBL] [Abstract][Full Text] [Related]
14. Postnatal deletion of β-catenin in osterix-expressing cells is necessary for bone growth and intermittent PTH-induced bone gain.
Yu C; Xuan M; Zhang M; Yao Q; Zhang K; Zhang X; Guo J; Song L
J Bone Miner Metab; 2018 Sep; 36(5):560-572. PubMed ID: 29124436
[TBL] [Abstract][Full Text] [Related]
15. Regulation of receptor activator of nuclear factor-kappa B ligand and osteoprotegerin mRNA expression by parathyroid hormone is predominantly mediated by the protein kinase a pathway in murine bone marrow cultures.
Lee SK; Lorenzo JA
Bone; 2002 Jul; 31(1):252-9. PubMed ID: 12110442
[TBL] [Abstract][Full Text] [Related]
16. Human trabecular bone-derived osteoblasts support human osteoclast formation in vitro in a defined, serum-free medium.
Atkins GJ; Kostakis P; Welldon KJ; Vincent C; Findlay DM; Zannettino AC
J Cell Physiol; 2005 Jun; 203(3):573-82. PubMed ID: 15573398
[TBL] [Abstract][Full Text] [Related]
17. Trapidil, a platelet-derived growth factor antagonist, inhibits osteoclastogenesis by down-regulating NFATc1 and suppresses bone loss in mice.
Kim SD; Kim HN; Lee JH; Jin WJ; Hwang SJ; Kim HH; Ha H; Lee ZH
Biochem Pharmacol; 2013 Sep; 86(6):782-90. PubMed ID: 23928189
[TBL] [Abstract][Full Text] [Related]
18. Beta-Arrestin2 regulates RANKL and ephrins gene expression in response to bone remodeling in mice.
Pierroz DD; Rufo A; Bianchi EN; Glatt V; Capulli M; Rucci N; Cavat F; Rizzoli R; Teti A; Bouxsein ML; Ferrari SL
J Bone Miner Res; 2009 May; 24(5):775-84. PubMed ID: 19113915
[TBL] [Abstract][Full Text] [Related]
19. Importance of membrane- or matrix-associated forms of M-CSF and RANKL/ODF in osteoclastogenesis supported by SaOS-4/3 cells expressing recombinant PTH/PTHrP receptors.
Itoh K; Udagawa N; Matsuzaki K; Takami M; Amano H; Shinki T; Ueno Y; Takahashi N; Suda T
J Bone Miner Res; 2000 Sep; 15(9):1766-75. PubMed ID: 10976996
[TBL] [Abstract][Full Text] [Related]
20. The calcium-sensing receptor complements parathyroid hormone-induced bone turnover in discrete skeletal compartments in mice.
Xue Y; Xiao Y; Liu J; Karaplis AC; Pollak MR; Brown EM; Miao D; Goltzman D
Am J Physiol Endocrinol Metab; 2012 Apr; 302(7):E841-51. PubMed ID: 22275754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
